DAILY EQUITY REPORT BY EPIC RESEARCH-24 SEPTEMBER 2012
Embed Size (px)
Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Commodity Tips, MCX Tips, Equity Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack and NCDEX Tips. We provide services in equity, commodity and Forex market.
Transcript of DAILY EQUITY REPORT BY EPIC RESEARCH-24 SEPTEMBER 2012
- HEADLINES Indian Market Indian equity markets up by 2.46%. Nifty up by 136.90 pts and settle at 5691.15. Sensex up by 403.59 pts at 18752.84. Bank Nifty up by 463.70 pts at 11384.50. DAILY EQUITY Global Market NEWSLETTER European markets were down with FTSE TH down by 9.01 pts at 5845.63 ,CAC up by 24 SEPTEMBER 2012 1.30 pts at 3511.22 and DAX down by 23.15 pts at 7412.64 Dow future up by 36.00 pts at 13629.00 HEADLINES Post Leapfrog tie-up M&M Insurance value Rs 520cr. UB Group, Diageo in final talks over valuations Walmart hopes to open first India store within 18 mnths. NTPC to raise $750m through bonds, syndicate loans WWW.EPICRESEARCH.CO 09993959693
- MARKET ANALYSIS: Key benchmark indices surged on the last trading session of the week, with the market sentiment boosted by the government on Thursday notifying the rules for allowing greater foreign investment in retail, aviation and broadcasting sectors. The governments announcement during trading hours today, 21 September 2012, of a reduction on taxes on overseas loans of local companies as well as announcement of a plan offering tax relief to retail equity investors, also boosted sentiment. The BSE Sensex was up 403.59 points or 2.2% to 18,752.84. The index jumped 517.62 points at the days high of 18,866.87 in early afternoon trade, its highest level since 26 July 2011. The S&P CNX Nifty was up 140.65 points or 2.53% to 5,694.90, as per provisional figures. Among the 30-share Sensex pack, 26 gained while only four of them declined. Index heavyweight and cigarette maker ITC advanced 1.77% to Rs 261. Index heavyweight Reliance Industries (RIL) rose 2.16%.Capital goods stocks rose on renewed buying. BEML, Bhel, ABB, Thermax and Siemens rose by between 1.41% to 7.3%.L&T gained 3.95% to Rs 1581.20.State Bank Of India jumped 4.29%,Axis Bank surged 7.56%. STOCKS TO WATCH FIIs and DIIs ANJANEYA LIFECARECATEGORY DATE BUY SELL NET TCS FII 21-Sep-12 6806.02 4478.2 2327.82 TATA GLOBAL AMBUJA DII 21-Sep-12 1758.29 2885.57 -1127.28 SCRIPS IN BAN PERIOD NIFTY DAILY PIVOTS PANTALOONRPIVOT R4 R3 R2 R1 PP S1 S2 S3 S4NIFTY 6098 5953 5808 5751 5663 5606 5518 5373 5228 SUZLON WELCORP WWW.EPICRESEARCH.CO 09993959693
- . -GAINERS AND LOOSERS EXPERT OPINION NIFTY DAILY NIFTY GAINERS Nifty looks UpwardsSCRIPS RATE VOL. PR. NET % Strategy: Buy on dips (000) CLOSE CHAN CHANGE GE Support:5660 Resistance: 5720Reliance 544.05 5505.29 495.80 48.25 9.73 Infra BANK NIFTY SAIL 92.65 7369.15 85.95 6.70 7.80 Bank Nifty looks Upwards Axis Strategy: Buy on dips 1124.65 5540.04 1044.40 80.25 7.68 Bank Support:11320 BHEL 232.40 11658.30 216.15 16.25 7.52 Resistance:11450 Jindal 426.90 8733.23 400.60 26.30 6.57 Steel PREVIOUS PERFORMANCE TYPE SCRIP B/S RESULT DAILY NIFTY LOOSERS NOT CASH APTECH SSCRIPS RATE VOL. PR. NET % EXECUTED (000) CLOSE CHAN TGT CASH R COMM B ACHIEVED GE BOMBAY TGT FUTURE DYEING S TCS 1304.05 2123.03 1322.00 -17.95 -1.36 ACHIEVED NOT Dr Reddys FUTURE TATA STEEL S 1643.70 822.05 1665.05 -21.35 -1.28 EXECUTED Lab Infosys 2593.30 1536.28 2617.20 -23.90 -0.91 Sun Pharma 669.50 1679.56 671.00 -1.50 -0.22 Inds. www.epicresearch.co 09993959693
- MARKET CALLS CASH ST ND SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS ANJANEYA LIFECARE SELL 707.00 700.00 690.00 714.00 TATA GLOBAL BUY 131.90 133.20 135.00 130.60 FUTURE ST ND SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS. ADANI BUY 204.70 206.70 209.70 202.70 AMBUJA BUY 196.40 197.40 199.00 195.40 Disclaimer The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them t he most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particul ar investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, togethe r with all estimates and forecasts, can change without